关注
Lokesh Narsineni
Lokesh Narsineni
在 mail.ubc.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
M Foldvari, DW Chen, N Nafissi, D Calderon, L Narsineni, A Rafiee
Journal of Controlled Release 240, 165-190, 2016
2672016
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
A Hakim, B Guido, L Narsineni, DW Chen, M Foldvari
Advanced drug delivery reviews 196, 114781, 2023
182023
Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development
DW Chen, L Narsineni, M Foldvari
Nanomedicine: Nanotechnology, Biology and Medicine 21, 102045, 2019
72019
Dicationic amino substituted gemini surfactants and their nanoplexes: improved synthesis and characterization of transfection efficiency and corneal penetration in vitro
L Narsineni, M Foldvari
Pharmaceutical Research 37 (7), 144, 2020
62020
BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexesin vivo
L Narsineni, DW Chen, M Foldvari
Journal of Ophthalmology Clinics and Research 359, 244-256, 2023
52023
Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation …
L Narsineni, PPN Rao, AT Pham, M Foldvari
Molecular Pharmaceutics 19 (8), 2737-2753, 2022
22022
Evaluation of transfection with gemini nanoparticles for retinal neuroprotection in a dynamic microfluidic cell culture system
L Narsineni, A Hakim, B Guido, M Foldvari
Precision Nanomedicine 7 (1), 1264-1278, 2024
2024
Development of Multi-Functionalized Gemini Nanoplexes for Non-Viral Neurotrophic Factor Gene Delivery to the Retina
L Narsineni, DWR Chen, M Foldvari
MOLECULAR THERAPY 28 (4), 471-472, 2020
2020
Development of Peptide-Modified Gemini Nanoplexes for Gene Delivery to the Retina
L Narsineni
University of Waterloo, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–9